These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Measuring anticholinergic drug exposure in older community-dwelling Australian men: a comparison of four different measures. Pont LG; Nielen JT; McLachlan AJ; Gnjidic D; Chan L; Cumming RG; Taxis K Br J Clin Pharmacol; 2015 Nov; 80(5):1169-75. PubMed ID: 25923961 [TBL] [Abstract][Full Text] [Related]
3. Comparative Associations Between Measures of Anti-cholinergic Burden and Adverse Clinical Outcomes. Hsu WH; Wen YW; Chen LK; Hsiao FY Ann Fam Med; 2017 Nov; 15(6):561-569. PubMed ID: 29133497 [TBL] [Abstract][Full Text] [Related]
5. Methodological challenges in determining longitudinal associations between anticholinergic drug use and incident cognitive decline. Kashyap M; Belleville S; Mulsant BH; Hilmer SN; Paquette A; Tu le M; Tannenbaum C J Am Geriatr Soc; 2014 Feb; 62(2):336-41. PubMed ID: 24417438 [TBL] [Abstract][Full Text] [Related]
6. Evaluation of anticholinergic burden of medications in older adults. West T; Pruchnicki MC; Porter K; Emptage R J Am Pharm Assoc (2003); 2013; 53(5):496-504. PubMed ID: 24030127 [TBL] [Abstract][Full Text] [Related]
7. Expert-based drug lists to measure anticholinergic burden: similar names, different results. Lertxundi U; Domingo-Echaburu S; Hernandez R; Peral J; Medrano J Psychogeriatrics; 2013 Mar; 13(1):17-24. PubMed ID: 23551407 [TBL] [Abstract][Full Text] [Related]
8. Anticholinergic Burden, Polypharmacy, and Cognition in Parkinson's Disease Patients with Mild Cognitive Impairment: A Cross-Sectional Observational Study. Sumbul-Sekerci B; Bilgic B; Pasin O; Emre M; Hanagasi HA Dement Geriatr Cogn Disord; 2022; 51(5):386-395. PubMed ID: 36273437 [TBL] [Abstract][Full Text] [Related]
9. Association of anticholinergic burden with cognitive and functional status in a cohort of hospitalized elderly: comparison of the anticholinergic cognitive burden scale and anticholinergic risk scale: results from the REPOSI study. Pasina L; Djade CD; Lucca U; Nobili A; Tettamanti M; Franchi C; Salerno F; Corrao S; Marengoni A; Iorio A; Marcucci M; Violi F; Mannucci PM Drugs Aging; 2013 Feb; 30(2):103-12. PubMed ID: 23239364 [TBL] [Abstract][Full Text] [Related]
10. Prevalence, risk factors and adverse outcomes of anticholinergic burden in patients with advanced chronic conditions at hospital admission. Sevilla-Sánchez D; Molist-Brunet N; González-Bueno J; Solà-Bonada N; Espaulella-Panicot J; Codina-Jané C Geriatr Gerontol Int; 2018 Aug; 18(8):1159-1165. PubMed ID: 29644803 [TBL] [Abstract][Full Text] [Related]
12. Association of Anticholinergic Drug Burden with Cognitive and Functional Decline Over Time in Older Inpatients: Results from the CRIME Project. Brombo G; Bianchi L; Maietti E; Malacarne F; Corsonello A; Cherubini A; Ruggiero C; Onder G; Volpato S Drugs Aging; 2018 Oct; 35(10):917-924. PubMed ID: 30191516 [TBL] [Abstract][Full Text] [Related]
13. Concordance Among 10 Different Anticholinergic Burden Scales in At-Risk Older Populations. Tristancho-Pérez Á; Villalba-Moreno Á; Santos-Rubio MD; Belda-Rustarazo S; Santos-Ramos B; Sánchez-Fidalgo S J Patient Saf; 2022 Jun; 18(4):e816-e821. PubMed ID: 34693926 [TBL] [Abstract][Full Text] [Related]
14. [The Effect of Patient Age on Anticholinergic Use in the Elderly Japanese Population -Differences between Four Anticholinergic Scales]. Kimura T; Kato D; Nishimura T; Van Schyndle J; Uno S; Yoshida M Yakugaku Zasshi; 2020; 140(5):701-710. PubMed ID: 32378674 [TBL] [Abstract][Full Text] [Related]
15. Systematic review on the use of anticholinergic scales in poly pathological patients. Villalba-Moreno AM; Alfaro-Lara ER; Pérez-Guerrero MC; Nieto-Martín MD; Santos-Ramos B Arch Gerontol Geriatr; 2016; 62():1-8. PubMed ID: 26518612 [TBL] [Abstract][Full Text] [Related]
16. Anticholinergic Drug Burden and Delirium: A Systematic Review. Egberts A; Moreno-Gonzalez R; Alan H; Ziere G; Mattace-Raso FUS J Am Med Dir Assoc; 2021 Jan; 22(1):65-73.e4. PubMed ID: 32703688 [TBL] [Abstract][Full Text] [Related]
17. Assessing Risks of Polypharmacy Involving Medications With Anticholinergic Properties. Hanlon P; Quinn TJ; Gallacher KI; Myint PK; Jani BD; Nicholl BI; Lowrie R; Soiza RL; Neal SR; Lee D; Mair FS Ann Fam Med; 2020 Mar; 18(2):148-155. PubMed ID: 32152019 [TBL] [Abstract][Full Text] [Related]
18. [Use of anticholinergic drugs among the elderly and a comparison between risk scales: a population-based study]. Miranda VIA; Silveira MPT; Lutz BH; Pirolli F; Zambiasi L; Bielemann RM; Gonzalez MC; Bertoldi AD Cien Saude Colet; 2022 Mar; 27(3):1087-1095. PubMed ID: 35293446 [TBL] [Abstract][Full Text] [Related]
19. Anticholinergic drug burden according to the anticholinergic drug scale and the German anticholinergic burden and their impact on cognitive function in multimorbid elderly German people: a multicentre observational study. Krüger C; Schäfer I; van den Bussche H; Bickel H; Fuchs A; Gensichen J; König HH; Maier W; Mergenthal K; Riedel-Heller SG; Schön G; Weyerer S; Wiese B; von Renteln-Kruse W; Langebrake C; Scherer M BMJ Open; 2021 Mar; 11(3):e044230. PubMed ID: 33757948 [TBL] [Abstract][Full Text] [Related]
20. Comparison of anticholinergic risk scales and associations with adverse health outcomes in older people. Salahudeen MS; Hilmer SN; Nishtala PS J Am Geriatr Soc; 2015 Jan; 63(1):85-90. PubMed ID: 25597560 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]